Clinical Trial Document Analysis

Clinical trial document analysis applies document AI to the extraordinary paper burden of drug and device development: protocols and amendments, informed consent forms, case report forms (CRFs), site regulatory binders, monitoring reports, safety narratives, lab reports, and the trial master file that must hold it all in inspectable order. Trials generate documentation at industrial scale — a single study can produce hundreds of thousands of pages — and much of it still originates as scans, faxes from sites, and semi-structured PDFs.

The analysis tasks map onto trial operations. Extraction digitizes CRF and source data, including the reconciliation between them that source data verification requires — comparing what the site recorded against the source documents, a traditionally manual monitoring cost that AI can target toward discrepancies. Protocol intelligence structures eligibility criteria, visit schedules, and endpoints, enabling automated checks that collected data matches protocol requirements and accelerating feasibility and amendment-impact analysis. Safety document processing extracts adverse-event details from narratives and source records against regulatory reporting clocks measured in days. And TMF automation classifies and indexes incoming documents against the reference model, flagging the gaps that inspections find.

The governing framework is strict: GxP quality expectations, ALCOA+ data-integrity principles, validated systems, and audit trails on everything — an extraction model operating on trial data is itself subject to fitness-for-purpose evidence. Patient privacy adds handling constraints across jurisdictions. Within those bounds, the payoff is substantial: faster database lock, monitoring effort concentrated where discrepancies actually are, safety signals surfaced from narrative sources sooner, and inspection readiness as a continuous state rather than a pre-inspection scramble.